Amgen (AMGN)

Operating Cash Flow (Statement)

$4.00B

Quarterly · Period ending: · USD

AMGN logo

AMGN Operating Cash Flow (Statement)

Latest reported$4.00B
AMGN Quarterly Cash from Operations (-$400.00K → $4.00B)
High-resolution chart · PNG

AMGN operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Amgen Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
352,300,000
315,400,000
371,700,000
606,600,000
362,000,000
294,300,000
191,300,000
318,900,000
364,400,000
200,700,000
280,000,000
246,500,000
222,200,000
292,800,000
237,300,000
195,700,000
237,800,000
232,100,000
276,800,000
150,500,000
302,000,000
93,300,000
225,000,000
189,600,000
202,300,000
156,300,000
184,100,000
130,400,000
100,700,000
116,700,000
188,000,000
144,800,000
105,900,000
-5,700,000
86,800,000
61,900,000
80,500,000
63,600,000
62,900,000
80,100,000
-12,300,000
-34,600,000
15,500,000
44,900,000
23,000,000
11,300,000
-15,200,000
-400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.